FCI
TEVA icon

Financial Counselors Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Financial Counselors Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-65,429
Closed -$1.01M – 472
2025
Q1 		$1.01M Sell
65,429
-4,718
-7% -$84.3K 0.02% 333
2024
Q4 		$1.55M Buy
70,147
+13,675
+24% +$249K 0.02% 293
2024
Q3 		$1.02M Sell
56,472
-109
-0.2% -$1.91K 0.02% 338
2024
Q2 		$919K Sell
56,581
-502
-0.9% -$7.73K 0.01% 331
2024
Q1 		$805K Sell
57,083
-954
-2% -$12K 0.01% 355
2023
Q4 		$606K Sell
58,037
-1,533
-3% -$14.3K 0.01% 375
2023
Q3 		$608K Buy
59,570
+1,672
+3% +$15.6K 0.01% 368
2023
Q2 		$436K Sell
57,898
-2,009
-3% -$16.3K 0.01% 381
2023
Q1 		$530K Sell
59,907
-272
-0.5% -$2.69K 0.01% 350
2022
Q4 		$549K Sell
60,179
-2,505
-4% -$21.9K 0.01% 357
2022
Q3 		$506K Sell
62,684
-284,313
-82% -$2.51M 0.01% 351
2022
Q2 		$2.61M Sell
346,997
-7,562
-2% -$65.9K 0.06% 221
2022
Q1 		$3.33M Buy
354,559
+43,417
+14% +$362K 0.07% 211
2021
Q4 		$2.49M Sell
311,142
-6,140
-2% -$55.4K 0.05% 234
2021
Q3 		$3.09M Buy
317,282
+29,268
+10% +$274K 0.07% 223
2021
Q2 		$2.85M Buy
288,014
+9,113
+3% +$96.5K 0.06% 231
2021
Q1 		$3.22M Buy
278,901
+24,468
+10% +$281K 0.07% 210
2020
Q4 		$2.46M Buy
254,433
+12,452
+5% +$119K 0.06% 235
2020
Q3 		$2.18M Buy
241,981
+8,807
+4% +$93.2K 0.06% 227
2020
Q2 		$2.88M Buy
233,174
+3,055
+1% +$34.6K 0.09% 197
2020
Q1 		$2.07M Buy
230,119
+59,338
+35% +$608K 0.09% 186
2019
Q4 		$1.67M Sell
170,781
-41,234
-19% -$368K 0.06% 237
2019
Q3 		$1.46M Buy
212,015
+66,724
+46% +$511K 0.06% 243
2019
Q2 		$1.34M Buy
145,291
+4,856
+3% +$58.6K 0.05% 252
2019
Q1 		$2.2M Buy
140,435
+15,630
+13% +$276K 0.09% 195
2018
Q4 		$1.92M Buy
124,805
+872
+0.7% +$17.9K 0.09% 199
2018
Q3 		$2.67M Sell
123,933
-651
-0.5% -$15.1K 0.12% 183
2018
Q2 		$3.03M Sell
124,584
-1,106
-0.9% -$22.6K 0.14% 174
2018
Q1 		$2.15M Buy
125,690
+28,142
+29% +$549K 0.1% 197
2017
Q4 		$1.85M Sell
97,548
-83,582
-46% -$1.26M 0.08% 223
2017
Q3 		$3.19M Buy
181,130
+40,531
+29% +$912K 0.16% 163
2017
Q2 		$4.67M Buy
140,599
+7,571
+6% +$234K 0.23% 137
2017
Q1 		$4.27M Buy
133,028
+36,636
+38% +$1.25M 0.22% 146
2016
Q4 		$3.49M Buy
+96,392
New +$3.85M 0.19% 153
2016
Q2 		$4.84M Buy
96,424
+11,083
+13% +$590K 0.29% 125
2016
Q1 		$4.57M Buy
85,341
+7,537
+10% +$442K 0.28% 125
2015
Q4 		$5.11M Buy
77,804
+723
+0.9% +$44.7K 0.33% 100
2015
Q3 		$4.35M Sell
77,081
-1,332
-2% -$86.4K 0.3% 119
2015
Q2 		$4.63M Sell
78,413
-1,361
-2% -$84K 0.3% 120
2015
Q1 		$4.97M Buy
79,774
+2,939
+4% +$171K 0.31% 112
2014
Q4 		$4.42M Sell
76,835
-382
-0.5% -$21.3K 0.28% 119
2014
Q3 		$4.15M Sell
77,217
-194
-0.3% -$10.3K 0.29% 115
2014
Q2 		$4.06M Sell
77,411
-3,166
-4% -$162K 0.28% 115
2014
Q1 		$4.26M Buy
80,577
+262
+0.3% +$12.1K 0.31% 111
2013
Q4 		$3.22M Buy
80,315
+3,854
+5% +$152K 0.24% 136
2013
Q3 		$2.89M Sell
76,461
-7,721
-9% -$301K 0.24% 137
2013
Q2 		$3.3M Buy
+84,182
New +$3.28M 0.27% 120

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Financial Counselors Inc's TEVA Position: Q2 2025 in Review

Financial Counselors Inc sold out of Teva Pharmaceuticals (TEVA) in Q2 2025, closing a stake of 65,429 shares — an estimated $1.01M sold.

Financial Counselors Inc first reported a position in TEVA in Q2 2013 and held it in 47 quarters. The position peaked at $5.11M in Q4 2015. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

  • Financial Counselors Inc reported no remaining Teva Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Financial Counselors Inc sold 65,429 Teva Pharmaceuticals shares in Q2 2025, an estimated $1.01M.
  • Financial Counselors Inc first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 47 quarters.
  • Financial Counselors Inc's Teva Pharmaceuticals position peaked at $5.11M in Q4 2015.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2025.

Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.